Timothy J. Scannell - Jul 1, 2023 Form 3 Insider Report for Renalytix plc (RNLX)

Role
Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Stock symbol
RNLX
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
3
Date filed
7/3/2023, 04:24 PM
Previous filing
Jun 9, 2023
Next filing
Nov 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RNLX Ordinary Shares 69K Jul 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNLX Stock Option (right to buy) Jul 1, 2023 Ordinary Shares 40K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.
F2 One fourth (1/4th) of the shares subject to the option award vested on March 30, 2023, and one sixteenth (1/16th) of the shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service.
F3 The exercise price is 2.76 pounds sterling. The U.S. dollar equivalent of the exercise price is $3.48 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney